NASDAQ · TDAC
Translational Development Acquisition Corp.
$10.85$0.00 (0.0%)
Translational Development Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
Loading market information…
OTC · WINV · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
WinVest Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow WinVest Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
WinVest Acquisition Corp. currently lacks significant operational activities. Its main goal is to finalize a strategic corporate alliance, which could encompass a merger, stock exchange, asset purchase, or other form of reorganization with one or more entities. The company specifically intends to complete its inaugural business combination with Insight Guru Inc., a technology firm specializing in business and financial data analytics. Incorporated in 2021, the company is headquartered in Cambridge, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.85$0.00 (0.0%)
Translational Development Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
$9.95$0.00 (0.0%)
Market Technology Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.5% below the high.
$10.17+$0.01 (+0.12%)
Insight Digital Partners II’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
$10.45+$0.01 (+0.1%)
Silver Pegasus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 5.26% below the high.
$10.12-$0.01 (-0.07%)
FortuneX Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 3.13% below the high.
$12.50$0.00 (0.0%)
Israel Acquisitions Corp.’s quoted price sits in the lower half of its reported 52-week range, 34.21% below the high.
$11.38-$0.06 (-0.52%)
Cayson Acquisition Corp Ordinary shares’s quoted price sits in the upper half of its reported 52-week range, 5.01% below the high.
$12.08$0.00 (0.0%)
Technology & Telecommunication Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 9.51% below the high.
